https://www.selleckchem.com/
2%) which occurred in the same quadrant of the breast index. The 3-year OSR was 89.8%. Treatment was well-tolerated with no grade 3-4 acute and late toxicity, and 87% of patients were recorded as excellent-good cosmesis. The use of BCS with IORT as a boost resulted in a low local recurrence rate and excellent cosmetic outcome in early breast cancer. #link# Thus, IORT as a boost could be considered as an alternative to an external beam boost. Prospective studies are needed to confirm this data. The use of BCS with IORT as a boost resulted in a low local recu
Like
Comment
Share
